1. Yachida S, Totoki Y, Noe M, Nakatani Y, Horie M, Kawasaki K, Nakamura H, Saito-Adachi M, Suzuki M, Takai E, Hama N, Higuchi R, Hirono S, Shiba S, Kato M, Furukawa E, Arai Y, Rokutan H, Hashimoto T, Mitsunaga S, Kanda M, Tanaka H, Takata S, Shimomura A, Oshima M, Hackeng WM, Okumura T, Okano K, Yamamoto M, Yamaue H, Morizane C, Arihiro K, Furukawa T, Sato T, Kiyono T, Brosens LAA, Wood LD, Hruban RH, Shibata T. Comprehensive genomic profiling of neuroendocrine carcinomas of the gastrointestinal system. Cancer Discov. 2022 Mar 1;12(3):692-711. doi: 10.1158/2159-8290.CD-21-0669 (本研究費をAcknowledgementsに記載).
2. Tomida A, Chiyonobu T, Tokuda S, Miyachi M, Murashima K, Hirata M, Nakagawa M, Iehara T, Kuroda J, Takayama K. Pleomorphic rhabdomyosarcoma in a young adult harboring a novel germline MSH2 variant. Hum Genome Var. 2022;9(1):8. doi: 10.1038/s41439-022-00185-x.
3. Takamiya A, Ishibashi Y, Makise N, Hirata M, Ushiku T, Tanaka S, Kobayashi H. Imaging characteristics of NTRK-rearranged spindle cell neoplasm of the soft tissue: A case report. J Orthop Sci. 2022:S0949-2658(21)00367-5. doi: 10.1016/j.jos.2021.11.002.
4. Liu X, Yamaguchi K, Takane K, Zhu C, Hirata M, Hikiba Y, Maeda S, Furukawa Y, Ikenoue T. Cancer-associated IDH mutations induce Glut1 expression and glucose metabolic disorders through a PI3K/Akt/mTORC1-Hif1α axis. PLoS One. 2021;16(9):e0257090. doi: 10.1371/journal.pone.0257090. eCollection 2021.
5. Nakagawa M, Kobayashi E, Yamada M, Watanabe T, Hirata M, Tanabe N, Ushiama M, Sakamoto H, Sato C, Mori T, Yoshida A, Yoshida T, Sugano K, Kawai A. Myxofibrosarcoma harboring an MLH1 pathogenic germline variant associated with Muir-Torre syndrome: a case report. Hered Cancer Clin Pract. 2021;19(1):34. doi: 10.1186/s13053-021-00192-z.
6. S. Kohsaka, M. Hirata M. Ikegami, T. Ueno, S. Kojima, T. Sakai, K. Ito, N. Naka, K. Ogura, A. Kawai, S. Iwata, T. Okuma, T. Yonemoto, H. Kobayashi, Y. Suehara, H. Hiraga, T. Kawamoto, T. Motoi, Y. Oda, D. Matsubara, K. Matsuda, Y. Nishida, H. Mano, Comprehensive molecular and clinicopathological profiling of desmoid tumours, Eur J Cancer, 145 (2021) 109-120. DOI: 10.1016/j.ejca.2020.12.001
7. Sugawara T, Miya F, Ishikawa T, Lysenko A, Nishino J, Kamatani T, Takemoto A,Boroevich KA, Kakimi K, Kinugasa Y, Tanabe M, Tsunoda T. Immune subtypes and neoantigen-related immune evasion in advanced colorectal cancer. iScience. 2022 Jan 6;25(2):103740. doi: 10.1016/j.isci.2022.103740. PMID: 35128352; PMCID:PMC8800070.